Chinese firm acquires majority stake in Weetabix
By John Reynolds, marketingmagazine.co.uk, Thursday, 03 May 2012 04:50PM
China's state-owned Bright Food company has taken a controlling interest in Weetabix, as the breakfast cereal gears up for a push in the Far East.
Bright Food announced today (4 May) that it had acquired a 60% majority stake in the Weetabix Food Company.
The deal values the Weetabix business at £1.2bn.
As part of the deal, Bright Food has also acquired the Weetabix sister brands, Alpen and Ready Brek.
The Northamptonshire-based company was family-owned until 2004, when it was acquired by Lion Capital.
According to Nielsen, Weetabix is the top-selling cereal brand in the UK.
In 2011, it registered sales of £135.1m, up 10.2% on the year, ahead of Kellogg's Special K with sales of £119.4m.
Lyndon Lea, a partner at Lion Capital, said: "We are excited to continue our journey with the Weetabix brand, which has been an enormously successful investment, as we extend the business into China in partnership with Bright Food."Follow John Reynolds on Twitter @johnreynolds10
This article was first published on marketingmagazine.co.uk
- Account Director: Liverpool Blue Skies Marketing Recruitment £40000 - £45000 per annum, Liverpool
- Junior Artworker #RETAIL #FASHION #CONSUMERGOODS #PACKAGING Creative Recruitment £23000 per annum, London
- INTEGRATED DESIGNER 70% DIGITAL 30% PRINT #HTML #INTERNALCOMMS Creative Recruitment £30000 per annum, London
- Junior Designer,Developer #HMTL #CSS Creative Recruitment £25000 per annum, London
- Digital Project Manager. #WEBBUILDS #MOBILEAPPS #TABLETAPPS Creative Recruitment £35000 - £45000 per annum, Berkshire
- Google's European leader says viewing habits are 'changing dramatically'
- Tesco media review pits Initiative against MediaCom and ZenithOptimedia
- Martin Sorrell talks Maurice Lévy, Tesco, and the global outlook
- Land Rover to move global ad account into Spark44
- Viacom to bring Breaking Bad to Freeview with Spike launch
- 'Advertisers are snake oil salesmen', says Peter Oborne